Flecainide Acetate
Rank #383 of 500 drugs by total cost
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$25.1M
Total Cost
412,334
Total Claims
$25.1M
Total Cost
9,401
Prescribers
$61
Cost per Claim
97,693
Beneficiaries
941,929
30-Day Fills
$2,671
Avg Cost/Provider
44
Avg Claims/Provider
Share of Medicare Part D Spending
0.01%
of total Medicare Part D spending
$25.1M of $275.65B
Top Prescribers by Cost
Top 10 prescribers of $25.1M total
Top Prescribers of Flecainide Acetate
| # | Provider | Specialty | Location | Claims | Cost |
|---|---|---|---|---|---|
| 1 | Mayer Rashtian | Clinical Cardiac Electrophysiology | Pasadena, CA | 704 | $56K |
| 2 | Peter Chung | Cardiology | Los Angeles, CA | 912 | $55K |
| 3 | David Kessler | Clinical Cardiac Electrophysiology | Austin, TX | 986 | $52K |
| 4 | David Fitzgerald | Clinical Cardiac Electrophysiology | Winston Salem, NC | 741 | $49K |
| 5 | Sukhvinder Bhajal | Cardiology | Visalia, CA | 690 | $48K |
| 6 | Raman Moradkhan | Clinical Cardiac Electrophysiology | Modesto, CA | 602 | $46K |
| 7 | Moeen Saleem | Clinical Cardiac Electrophysiology | Naperville, IL | 466 | $44K |
| 8 | Patrick Welch | Clinical Cardiac Electrophysiology | Lafayette, LA | 1,047 | $41K |
| 9 | Jeffrey Mahoney | Clinical Cardiac Electrophysiology | Omaha, NE | 564 | $40K |
| 10 | David Rodak | Clinical Cardiac Electrophysiology | Spartanburg, SC | 618 | $40K |
| 11 | Corey Coleman | Clinical Cardiac Electrophysiology | Birmingham, AL | 541 | $38K |
| 12 | Charles Moore | Nurse Practitioner | Huntington, WV | 661 | $37K |
| 13 | Zoheir Abdelbaki | Cardiology | Lima, OH | 527 | $36K |
| 14 | Darren Jones | Clinical Cardiac Electrophysiology | Portland, OR | 504 | $35K |
| 15 | Karen Sherk | Nurse Practitioner | Edina, MN | 337 | $35K |
Top prescribers ranked by total cost for this drug in 2023.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 380 | Amoxicillin/Potassium Clav (Amoxicillin-Clavulanate Potass) | $25.3M | 2,207,997 |
| 381 | Infliximab (Remicade) | $25.3M | 3,457 |
| 382 | Glimepiride (Glimepiride) | $25.3M | 1,885,737 |
| 383 | Flecainide Acetate (Flecainide Acetate) | $25.1M | 412,334 |
| 384 | Pioglitazone Hcl (Pioglitazone Hcl) | $24.8M | 1,182,614 |
| 385 | Fremanezumab-Vfrm (Ajovy Autoinjector) | $24.7M | 29,389 |
| 386 | Nitrofurantoin Monohyd/M-Cryst (Nitrofurantoin Mono-Macro) | $24.4M | 1,173,249 |
Related Analysis
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology